secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2025-10-23T23:59:59+00:00
Accession:  0001683168-25-007750
Event type: leadership
Sentiment:  negative
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharma terminates EVP/COO Bruce Thornton for cause, effective Oct 18
---------------------------------------------------------------------------

- Bruce Thornton terminated as EVP and Chief Operating Officer on October 18, 2025.
- Termination was for cause under his employment agreement; no severance or future benefits.
- Thornton will only receive salary and benefits earned through the termination date.
- CEO Amy Trombly signed the 8-K confirming the departure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316825007750/0001683168-25-007750-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316825007750/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-007750

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer